Clinical Trials · NCT06859268
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 643
- Start date
- Mar 2025
- Locations
- 53 sites, 3 countries
- Primary endpoint
- Percent Change from Baseline in Body Weight